Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Lttl vs Embody

An in-depth comparison of two leading GLP-1 Providers

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Lttl logo

Lttl

8.2
★★★★4.1/5

Best for: starting below a standard dose, with microdose tiers

Visit Lttl
VS
Embody logo

Embody

9.3
★★★★4.7/5

Best for: knowing which pharmacy fills the vial — it names RedRock Pharmacy

Visit Embody

Two GLP-1 Providers chasing the same patients, trading off price, geography and what lands in the box differently. On our scoring, Embody opens cheaper — $79/mo against $149, and Embody finishes ahead, 9.3 to 8.2. What follows: the prices, what each plan actually covers, the six-dimension score, where each one is weak, and who should pick which.

Pricing

Lttl

Injectable, monthly auto-refill (flat across all dosages)Compounded
$199$149/mo
Save 25% right now
semaglutide

Month-to-month 'Monthly Auto-Refill' rate, was $249. Commitment ladder published on /plans: $169/mo billed $507 quarterly, $149/mo billed $894 every 6mo, $129/mo billed $1,548 annually. Promo is a one-time 'First Month Special' at $149 ('$149 - first month only'). The homepage 'Plans start at $129/mo' headline is the 12-month prepay rate.

Injectable, monthly auto-refill (flat across all dosages)Compounded
$279$199/mo
Save 29% right now
tirzepatide

Month-to-month rate, was $339. Ladder: $249/mo billed $747 quarterly, $229/mo billed $1,374 every 6mo, $199/mo billed $2,388 annually. One-time First Month Special $199. The '$199 per month' figure advertised on /weight-loss is the 12-month prepay rate.

Oral ODT (dissolving tablet), monthly auto-refillCompounded
$229$179/mo
Save 22% right now
semaglutide

Needle-free oral option. Month-to-month, was $279. Ladder: $199 quarterly, $179 every 6mo, $159 annually. First Month Special $179.

Microdose injectable, monthly auto-refillCompounded
$149$119/mo
Save 20% right now
semaglutide

Low-dose line marketed for tolerability. Month-to-month, was $179. Ladder: $129 quarterly, $119 every 6mo, $109 annually. First Month Special $119.

Microdose injectable, monthly auto-refillCompounded
$149$119/mo
Save 20% right now
tirzepatide

Low-dose GLP-1 + GIP. Same ladder as microdose semaglutide: $129 quarterly, $119 every 6mo, $109 annually. First Month Special $119.

Microdose oral ODT, monthly auto-refillCompounded
$179$149/mo
Save 17% right now
semaglutide

Month-to-month, was $209. Ladder: $159 quarterly, $149 every 6mo, $139 annually. First Month Special $149.

Embody

Injection — flat at every doseCompounded
$79/mo
semaglutide

Checkout: '$79/mo flat forever' (strikethrough $299); bundles $76/$73/$69 per month on 3/6/12-mo. CAVEAT: T&C list price is $199/mo — the $79 depends on the auto-applied SUMMER promo marketed as permanently locked; Trustpilot complaints allege the lock was not always honored.

Injection — flat at every doseCompounded
$129/mo
tirzepatide

Checkout tile 'Flat rate at $119/month (strikethrough $349)'; homepage 'starting at $129/month'; bundles $126/$123/$119 per month.

OralCompounded · oral
$229/mo
semaglutide

New oral semaglutide $229/mo.

Oral / gumCompounded · oral
$329/mo
tirzepatide

Oral tirzepatide $329/mo; gum bundles to $299/mo at 12-month.

What’s included

Lttl

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

Embody

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

Score breakdown

Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.

Lttl

8.2/10

Overall

Embody

9.3/10

Value25%

9.2A
vs
B
10.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

6.5A
vs
B
9.0

Accessibility10%

5.0A
vs
B
10.0

Support10%

7.0A
vs
B
7.0

Features & Coverage

FeatureLttlEmbody
Starting Price$149/mo$79/mo
Features8 features6 features
States AvailableNot disclosed50
Compounded✓ Yes✓ Yes
Brand Name
FSA/HSA Accepted✓ Yes
FDA WarningsNoneNone

About Lttl

Prepay for 12 months and compounded semaglutide drops to $129 with tirzepatide at $199; taken month to month they run $199/mo and $279/mo, one flat rate at any dose. Before checkout the entire price matrix is on view, every commitment length, form and medication in it. Longevity peptides and a microdose line at low dose fill out the direct-to-consumer catalog. The name is said aloud as little.

Read our full Lttl review →

About Embody

Embody sells compounded semaglutide and tirzepatide by injection, plus a compounded oral tirzepatide gum that is unique in the category. Flat-rate pricing is aggressive, coverage runs to all 50 states, and clinician messaging is available 24/7 under a board-certified internal medicine CMO.

Read our full Embody review →

Pros & Cons

Lttl

What we like

  • Tirzepatide at $149 a month, 44% below the $267 median for the same drug and form across this register
  • Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
  • The monthly price is recorded as flat across doses, so it does not climb as the dose is titrated up
  • The monthly figure covers medication, consult, shipping
  • No FDA warning letter matched this operator when we searched our enforcement register

Watch-outs

  • No state list is on record here, so whether it serves your state cannot be confirmed from this page
  • No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Embody

What we like

  • Semaglutide at $79 a month, 58% below the $189 median for the same drug and form across this register
  • Tirzepatide at $129 a month, 52% below the $267 median for the same drug and form across this register
  • Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
  • The monthly figure covers medication, consult, shipping
  • Coverage is published for all 50 states
  • Names 4 dispensing pharmacies, which most sellers in this register do not do
  • No FDA warning letter matched this operator when we searched our enforcement register
  • Both oral and injectable options are on record, so the format is a choice rather than a condition

Watch-outs

  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: Embody

Embody takes it, 9.3 against 8.2, and it is especially strong on knowing which pharmacy fills the vial — it names RedRock Pharmacy. Lttl is no weak second and may fit you better on starting below a standard dose, with microdose tiers.

Choose Lttl if…

You want starting below a standard dose, with microdose tiers and an opening price near $149 a month.

Choose Embody if…

You want knowing which pharmacy fills the vial — it names RedRock Pharmacy and an opening price near $79 a month.

Ready to start? Vetted GLP-1 providers

Vetted telehealth providers that prescribe GLP-1 online.

No insurance needed · vetted by our editors

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

8.8

Gala

Moving between compounded and brand without changing seller

9.4

Trimi Health

Knowing which pharmacy fills the vial — it names VialsRx

8.5

Strut Health

Semaglutide at $99/month, 48% under the register median

Lttl vs Embody: FAQ

Glossary

The words sellers use, defined. Tap any term.

Continue exploring Lttl and Embody head-to-heads in the same category.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.